(Q58329626)

English

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study

scientific article published on 19 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

0 references

acute coronary syndrome

1 reference

based on heuristic

inferred from title

Kerstin Brismar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Camilla Hage

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pia Lundman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Lars Rydén

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

0 references

publication date

19 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

290-293

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Reproducibility of different methods to measure the endothelial function.

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design

1 reference

https://api.crossref.org/works/10.1177%2F1479164114533355

21 January 2018

Identifiers

10.1177/1479164114533355

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24845072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58329626&oldid=2136011590"